Pharma companies lead topline growth in Q1FY22: ICICI Direct Research
Corporate earnings for April-June were robust despite the second wave of Covid-19 and a report by ICICI Direct
Read moreCorporate earnings for April-June were robust despite the second wave of Covid-19 and a report by ICICI Direct
Read more